Anticancer Agents


Kinase Inhibitors
Target Development Name(s) Generic Name(s) Trade
Name(s)
Notes
ABL AMN107 nilotinib Tasigna
AP24534​ ponatinib Iclusig
AS703569, R763 cenisertib

AT9283​


BMS-354825 dasatinib Sprycel
INNO-406, NS-​187 bafetinib​

SKI-606 bosutinib Bosulif
STI-571, CGP57148, CGP57148B​ imatinib​ Gleevec
XL228

AKT AS703569, R763 cenisertib
catalytic inhibitor
AT13148


AZD5363

catalytic inhibitor
BAY1125976


GDC-0068 ipatasertib
catalytic inhibitor​
GSK2110183 afuresertib

GSK2141795 uprosertib

MK-2206

allosteric inhibitor
ALK
(Anaplastic Lymphoma Kinase)
AP26113


ASP3026


CH5424802, RO5424802, AF802 alectinib

LDK378 ceritinib Zykadia
PF-02341066 crizotinib Xalkori
PF-06463922


RXDX-101


TSR-011


X-396


Aurora A AS703569, R763 cenisertib

AT9283


ENMD-2076


MK5108


MLN8237 alisertib

PF-03814735


TAK901


Aurora B AS703569, R763 cenisertib

AT9283


AZD1152-HQPA, AZD1152 barasertib


GSK1070916


PF-03814735


Aurora C GSK1070916


Aurora A/B/C AMG900


BI 847325


PHA-739358 danusertib

SNS-314


BRAF ARQ 736


GSK2118436 dabrafenib Tafinlar
PLX-4032, RG7204, R05185426 vemurafenib Zelboraf
RAF265


RO5212054, PLX3603


BTK AS703569, R763 cenisertib

AVL-292


PCI-32765 ibrutinib Imbruvica
CDK 1,2,4,5,6,7,9 (pan-CDK) HMR-1275, L868275, flavopiridol alvocidib

CDK 1,2,4,7,9 (pan-CDK) BAY 1000349 roniciclib

CDK 1,2,5,9 SCH727965 dinaciclib

CDK 2,7,9 CYC202 seliciclib

CDK 4,6 LEE011 abemaciclib

LY2835219


PD 0332991 palbociclib

CHEK1 LY2606368


CSF-1R PLX3397, PLX108-01


PLX7486


EGFR (HER1/ERBB1) AEE788, NVP-AEE788


AP26113

wild type-sparing EGFR inhibitor
ASP8273

wild type-sparing EGFR inhibitor
AZD6474, ZD6474 vandetanib Zactima, Caprelsa
AZD9291

wild type-sparing EGFR inhibitor
BIBW-2992 afatinib Gilotrif, Tomtovok
BPI-2009H icotinib

CI-1033, PD183805 canertinib

CO-1686 rociletinib
wild type-sparing EGFR inhibitor
EGF816

wild type-sparing EGFR inhibitor
HM61713

wild type-sparing EGFR inhibitor
HMPL-813 epitinib


MNPL-309 theliatinib

OSI-774, CP-258,774 erlotinib Tarceva
XL647, KD019


ZD1839 gefitinib Iressa
EGFR (HER1/ERBB1)
HER2 (ERBB2/neu)
HER3 (ERBB3)
AZD8931


EGFR (HER1/ERBB1)
HER2 (ERBB2/neu)
HER4 (ERBB4)
BMS-599626, AC480


BMS-690514, EVRI


EKB-569 pelitinib

HM781-36B poziotinib

PF-00299804 dacomitinib

EphB4 XL647, KD019


FAK AB1010 masitinib Masivet
GSK2256098


VS-4718


VS-6063 defactinib

FGFR1/2/3 AB1010 masitinib Masivet
AP24534 ponatinib Iclusig
AZD4547


BGJ398, NVP-BGJ398


BIBF1120 nintedanib Vargatef
Debio 1347, CH5183284
E-3810 lucitanib

HMPL-012 sulfatinib

LY2874455


TKI258, CHIR-258 dovitinib

XL228

FGFR1/2/3/4 JNJ-42756493


FGFR1 TSU 68, SU6668 orantinib

FGFR3 ENMD-2076


FLT3 AC220 quizartinib

AP24534 ponatinib Iclusig
AS703569, R763 cenisertib

BAY 43-9006 sorafenib Nexavar
CEP-701 lestaurtinib

CP-868569 crenolanib

ENMD-0276


MLN518, CT53518 tandutinib

MP-470 amuvatinib

PKC412 midostaurin

PLX3397, PLX108-01


SU-11248 sunitinib Sutent
XL184 cabozantinib Cometriq
HER2 (ERBB2/neu) AEE788, NVP-AEE788


ARRY 380


BIBW-2992 afatinib Gilotrif, Tomtovok
CI-1033, PD183805 canertinib

GSK572016, GW2016, GW-572016 lapatinib Tykerb
HKI-272 neratinib

TAK 165 mubritinib

XL647, KD019


IGF-1R BMS-536924


BMS-754807


OSI-906 ​linsitinib

XL228

JAK1 PRT062070


JAK1/2 AZD1480


CYT-387, CYT387 momelotinib

INCB018424 ruxolitinib Jakafi
JAK2 AT9283


BMS-911543


CEP-701 lestaurtinib

SAR302503, TG101348 fedratinib

SB1518 pacritinib

XL019


JAK2 V617F SB1518 pacritinib

LY2784544


XL019


JAK3 CP-690550 tofacitinib citrate Xeljanz
PRT062070


KIT AB1010 masitinib Masivet
AG-013736 axitinib Inlyta
AMG706 motesanib

AS703569, R763 cenisertib

BAY 57-9352 telatinib

BAY 73-4506 regorafenib Stivarga
BMS-354825 dasatinib Sprycel
GW786034 pazopanib Votrient
MLN518, CT53518 tandutinib

MP-470 amuvatinib

PKC412 midostaurin

PLX3397, PLX108-01


STI-571, CGP57148, CGP57148B imatinib Gleevec
SU-11248 sunitinib Sutent
XL184 cabozantinib Cometriq
XL820


LYN INNO-406, NS-187 bafetinib

AS703569, R763 cenisertib

MAPK1 (ERK) BVD-523


MK-8353, SCH900353


MEK AS703026, MSC1936369B pimasertib

AZD6244, ARRY-142886 selumetinib

AZD8330


BAY 86-9766, RDEA119 refametinib

BI 847325


CI-1040


GDC-0623


GDC-0973 cobimetinib

GSK1120212 trametinib Mekinist
MEK162 binimetinib

PD0325901, PD-0325901


RO5126766, CH5126766


TAK-733


MET AMG 208


AMG 337


ARQ 197 tivantinib

BMS-777607


EMD 1214063, MSC2156119J


EXEL-2880, GSK1363089, XL880 foretinib

HMPL-504 volitinib

INCB028060, INC280


MGCD265


MK-2461


MP-470 amuvatinib

PF-02341066 crizotinib Xalkori
PF-04217903


SAR125844


XL184 cabozantinib Cometriq
MST1R MGCD265


mTOR AP23573, MK8669 ridaforolimus (deforolimus)
rapalogue​
AY 22989, SILA 9268A, WY-090217 sirolimus Rapamune rapalogue​​
AZD2014


AZD8055

TORC1/2, catalytic inhibitor​
BEZ235, NVP-BEZ235 dactolisib
catalytic, dual PI3K/mTOR inhibitor
BGT226, NVP-BGT226

dual PI3K/mTOR inhibitor
CC-223


CCI-779 temsirolimus Torisel rapalogue​
GDC-0980 apitolisib
catalytic, dual PI3K/mTOR inhibitor
MLN0128, INK128

TORC1/2, catalytic inhibitor​
OSI-027

TORC1/2, catalytic inhibitor​
PF-4691502

catalytic, dual PI3K/mTOR inhibitor
PI-103

catalytic, dual PI3K/mTOR inhibitor
PKI-587, PF-05212384 gedatolisib
pan-PI3K inhibitor, catalytic, dual PI3K/mTOR inhibitor
PWT33597

catalytic, dual PI3K/mTOR inhibitor
RAD001 everolimus Afinitor rapalogue​
SF1126

catalytic, dual PI3K/mTOR inhibitor
XL765, SAR245409 voxtalisib
catalytic, dual PI3K/mTOR inhibitor
NTRK1/2/3
(TRKA/B/C)
AZD7451


LOXO-101


PLX7486


RXDX-101


TSR-011


NTRK1 (TRKA) CEP-701 lestaurtinib

PDGFR AMG706 motesanib

BIBF1120 nintedanib Vargatef
GW786034 pazopanib Votrient
MLN518, CT53518 tandutinib

STI-571, CGP57148, CGP57148B imatinib Gleevec
X-82

inhibits all isoforms
PDGFRα CP-868569 crenolanib

MP-470 amuvatinib

PKC412 midostaurin

PDGFRβ ABT-869 linifanib

AG-013736 axitinib Inlyta
BAY 43-9006 sorafenib Nexavar
BAY 57-9352 telatinib

BAY 73-4506 regorafenib Stivarga
SU-11248 sunitinib Sutent
TSU 68, SU6668 orantinib

XL820


PI3K BAY 80-6946 copanlisib
pan-PI3K inhibitor
BEZ235, NVP-BEZ235 dactolisib
catalytic, dual PI3K/mTOR inhibitor
BGT226, NVP-BGT226 buparlisib
dual PI3K/mTOR inhibitor
BKM120

pan-PI3K inhibitor
BYL719


GDC-0941

pan-PI3K inhibitor
GDC-0980 apitolisib
catalytic, dual PI3K/mTOR inhibitor
GSK2636771


PF-4691502

catalytic, dual PI3K/mTOR inhibitor
PI-103

catalytic, dual PI3K/mTOR inhibitor
PKI-587, PF-05212384 gedatolisib
pan-PI3K inhibitor, catalytic
PWT33597

catalytic, dual PI3K/mTOR inhibitor
PX-866


SF1126

catalytic, dual PI3K/mTOR inhibitor
XL147, SAR245408 pilaralisib
pan-PI3K inhibitor
XL765, SAR245409 voxtalisib
catalytic, ​dual PI3K/mTOR inhibitor

sophoretin, quercetin

PI3Kα BYL719


GDC-0032 taselisib

INK-1117


PI3Kδ CAL-101, GS-1101 idelalisib Zydelig
TGR-1202


PI3Kδ/γ IPI-145, INK-1197 duvelisib

PKC
sophoretin, quercetin

PKCα LY317615 enzastaurin

PKC412 midostaurin

PKCβ LY317615 enzastaurin

PKCγ LY317615 enzastaurin

PKCε LY317615 enzastaurin

PLK1 BI 6727 volasertib

BI 2536


GSK461364, GSK-461364


NMS-1286937


ON 01910.Na rigosertib Estybon
RAF BAY 43-9006 sorafenib Nexavar
BAY 73-4506 regorafenib Stivarga
LGX818 encorafenib

MLN2480


RO5126766, CH5126766


XL281, BMS-908662


RET AMG706 motesanib

AZD6474, ZD6474 vandetanib Zactima, Caprelsa
BAY 43-9006 sorafenib Nexavar
BAY 73-4506 regorafenib Stivarga
MP-470 amuvatinib

SU-11248 sunitinib Sutent
XL184 cabozantinib Cometriq
ROS1 PF-02341066 crizotinib Xalkori
PF-06463922


RXDX-101


RPS6KB1 (p70S6K) AT13148


SCFR AB1010 masitinib Masivet
SRC AZD0530 saracatinib

BMS-354825 dasatinib Sprycel
KX2-391


XL228

SYK PRT062070


R788 fostamatinib​

TBK1 CYT-387, CYT387 momelotinib

TEK MGCD265


XL184 cabozantinib Cometriq
TGFBR1 LY2157299 galunisertib

TEW-7197


TORC1/2 AZD8055

catalytic inhibitor​
MLN0128, INK128

catalytic inhibitor​
OSI-027

catalytic inhibitor​
VEGFR ABT-869 linifanib

ENMD-2076


EXEL-2880, GSK1363089, XL880 foretinib

HMPL-012 sulfatinib

PTK 787, CGP 79787, ZK 222584 vatalanib

TSU 68, SU6668 orantinib

X-82

inhibits all isoforms
XL647, KD019


VEGFR1/2/3 AG-013736 axitinib Inlyta
AMG706 motesanib

BAY 73-4506 regorafenib Stivarga
BIBF1120 nintedanib Vargatef
E-3810 lucitanib

GW786034 pazopanib Votrient
HMPL-013 fruquintinib

KRN951, AV-951 tivozanib

MGCD265


VEGFR2 AEE788, NVP-AEE788


AP24534 ponatinib Iclusig
AZD2171 cediranib

AZD6474, ZD6474 vandetanib Zactima, Caprelsa
BAY 43-9006 sorafenib Nexavar
BMS-582664 brivanib

BMS-690514, EVRI


E7080 lenvatinib

PKC412 midostaurin

RAF265


SU-11248 sunitinib Sutent
XL184 cabozantinib Cometriq
XL820


YN968D1 apatinib

VEGFR2/3 BAY 57-9352 telatinib

E7080 lenvatinib

WEE1 AZD1775, MK1775



Therapeutic Antibodies
Target Development Name(s) Generic Name(s) Trade
Name(s)
Notes
ANGPT1/2 (ANG1/2) AMG 780


ANGPT2 (ANG2) MEDI-3617


REGN910 nesvacumab

RO5520985, RG7221


BAFF
belimumab Benlysta
CCR4 KW-0761 mogamulizumab

CD19 MEDI-551  

CD19/CD3 MT103, MT-103, MEDI-538 blinatumomab Blincyto
CD20 GA101 obinutuzumab Gazyvaro
IDEC-102, IDEC-C2B8 rituximab Rituxan, Mabthera
IDEC Y2B8 ibritumomab tiuxetan Zevalin drug can be bound via tiuxetan to 111In or 90Y

ofatumumab Arzerra, HuMax-CD20

tositumomab Bexxar drug can be bound with or without 131iodine
CD22 CAT-8015 moxetumomab pasudotox

CD27 CDX-1127 varlilumab

CD33
gemtuzumab Mylotarg
CD37 TRU-016 otlertuzumab

CD38
daratumumab HuMax-CD38
SAR650984


CD52 Campath alemtuzumab

CD70 ARGX-110

CD74 hLL1 milatuzumab

CD105 TRC105


CD248 (TEM1) MORAb-004 ontuxizumab

CTLA4 CP675,206 tremelimumab

MDX-010, MDX-101, BMS-734016 ipilimumab Yervoy
DLL4 OMP-21M18 demcizumab

EGFL7 MEGF0444A parsatuzumab

EGFR (HER1/ERBB1) ABT-806, mAb-806


ABX-EGF panitumumab Vectibix
h-R3, TheraCIM nimotuzumab

IMC-11F8 necitumumab

IMC-C225 cetuximab Erbitux
MEHD7945 A duligotuzumab

MM-151


RO5083945, GA201 imgatuzumab

Sym004 futuximab

FZD7 OMP-18R5 vantictumab

HER2 (ERBB2/neu) GT-Mab 7.3-GEX glycooptimized trastuzumab-GEX 

MGAH22 margetuximab

MM-111


MOAB 2C4 pertuzumab Perjeta, Omnitarg

trastuzumab Herceptin
HER3 (ERBB3) AV 203


LJM716


MEHD7945 A duligotuzumab

MM-111


MM-121, SAR256212 seribantumab

MM-141


REGN1400


U3-1287, AMG 888 patritumab

HGF AMG 102 rilotumumab

AV-299, SCH900105 ficlatuzumab

IGF-1R AMG-479 ganitumab

BI 836845


BIIB022


CP-751871 figitumumab

IMC-A12 cixutumumab

MEDI-573


MK-0646 dalotuzumab

MM-141


IGF-2R BI 836845


MEDI-573


KIR BMS-986015 lirilumab

MET ABT-700


LY2875358 emibetuzumab

MetMAb, R05490258, OA-5D onartuzumab

MMP9 GS-5745


PD-1 AMP-224


BMS-936558, MDX-1106, ONO-4538 nivolumab

CT-011 pidilizumab

MK-3475, lambrolizumab pembrolizumab Keytruda
PD-L1 MDX-1105, BMS-936559


MEDI-4736


MPDL3280A, RG7446


MSB0010718C


PDGFRα IMC-3G3 olaratumab

MEDI-575 tovetumab

PIGF
ziv-aflibercept Zaltrap
RANKL
denosumab Xgeva
SEMA4D VX15/2503


TGFBR2 IMC-TR1


TNFRSF9 (CD137/4-1BB) BMS 663513 urelumab

PF-05082566


TRAIL-R1/DR4,R2/D5 AMG951, rhApo2L/TRAIL dulanermin

TRAIL-R1/D4 HGS-ETR1 mapatumumab

TRAIL-R2/D5 AMG-655 conatumumab

HGS-ETR2 lexatumumab

LBY135


PRO95780 apomab

VEGFA
bevacizumab Avastin
RO5520985, RG7221



ziv-aflibercept Zaltrap
VEGFB
ziv-aflibercept Zaltrap
VEGFC VGX-100


VEGFR2 IMC-1121B ramucirumab Cyramza

Antibody-Drug Conjugates
Target Drug conjugate Development Name(s) Generic Name(s) Trade
Name(s)
Notes
CD19 maytansinoid DM4 SAR3419


CD22 calicheamycin CMC-544 inotuzumab ozogamicin

monomethyl auristatin E RG7593, DCDT2980S pinatuzumab vedotin

CD30 monomethyl auristatin E SGN-35 brentuximab vedotin Adcetris
CD33 calicheamycin
gemtuzumab ozogamicin Mylotarg
CD56 maytansinoid DM1 IMGN-901 lorvotuzumab mertansine

CD70 Prodrug of duocarmycin analogue BMS-936561, MDX-1203


CD79b monomethyl auristatin E RG7596, DCDS4501A polatuzumab vedotin

CEACAM5 SN-38 IMMU-130


EGFR monomethyl auristatin F ABT414


EGFRvIII maytansinoid DM1 AMG 595


FOLH1 (PSMA) monomethyl auristatin E PSMA ADC


FOLR1 maytansinoid DM4 IMGN853


GPNMB monomethyl auristatin E CDX-011 glembatumumab vedotin

GUCY2C (GCC) monomethyl auristatin E MLN0264


HER2 (ERBB2/neu) maytansinoid DM1 PRO132365 ado trastuzumab emtansine Kadcyla
Mesothelin Monomethyl auristatin E DMOT4039A


Nectin-4 Monomethyl auristatin E AGS-22M6E


SLC34A2 (NaPi2b) monomethyl auristatin E DNIB0600A, RG7599 lifastuzumab vedotin

STEAP1 monomethyl auristatin E DSTP3086S, RG7450


TACSTD2 (TROP2) SN-38 IMMU-132



Immunotherapies
Target Development Name(s) Generic Name(s) Trade
Name(s)
Notes
CD227 (MUC1) BLP25 tecemotide

CTLA4 CP675,206 tremelimumab

MDX-010, MDX-101, BMS-734016 ipilimumab Yervoy
IDO1 INCB024360


NLG-919


IL-6
siltuximab Sylvant
IL-6R R-1569 tocilizumab Actemra
IL-1β ACZ885 canakinumab Ilaris
KIR BMS-986015 lirilumab

PD-1 AMP-224


BMS-936558, MDX-1106, ONO-4538 nivolumab

CT-011 pidilizumab

MK-3475, lambrolizumab pembrolizumab Keytruda
PD-L1 MDX-1105, BMS-936559


MEDI-4736


MPDL3280A, RG7446


MSB0010718C


SEMA4D VX15/2503


TNFRSF9 (CD137/4-1BB) BMS 663513 urelumab

PF-05082566


Other Ad.p53 DC vaccine cancer vaccine
AGS-003 cancer vaccine
APC8015 sipuleucel-T Provenge cancer vaccine
BPX-201

cancer vaccine
CDX-1401


CG8123, GVAX

cancer vaccine
DCVAC/Pca

cancer vaccine
ETBX-011

cancer vaccine
GI-6301 cancer vaccine
HS-410 vesigenurtacel-L cancer vaccine
IMA901 cancer vaccine
MAGE-A3

cancer vaccine
OncoVex GM-CSF, T-VEC taliminogene laherparepvec
cancer vaccine
ONT-10

cancer vaccine
polyvalent melanoma vaccine, PMCV

cancer vaccine
PSA/IL-2/GM-CSF vaccine

cancer vaccine
TG4010, MVA-MUC1-IL2

cancer vaccine
TheraCys BCG vaccine
cancer vaccine
TSF aldesleukin Proleukin
VGX-3100

cancer vaccine

belagenpumatucel-L Lucanix cancer vaccine
enadenotucirev


interferon alpha-2b Intron A

peginterferon alfa-2b PEG-Intron

Chemotherapies
Type of Chemotherapy Subtype Generic Name(s) Trade
Name(s)
Notes
Alkylating Agents Alkyl sulfonates busulfan Busulfex, Myleran
Ethylenimines thiotepa Girostan
Nitrogen mustard bendamustine Treanda, Ribomustin
chlorambucil Leukeran
cyclophosphamide Cytoxan
ifosfamide Ifex
melphalan Alkeran
palifosfamide tris

Nitrosoureas carmustine BiCNU, Gliadel
lomustine CeeNU
streptozocin Zanosar
Platinum analogues carboplatin Paraplatin
cisplatin Platinol
oxaliplatin Eloxatin
Triazenes dacarbazine DTIC-Dome
temozolomide Temodar
Other procarbazine Matulane
Antimetabolites Folate antagonists methotrexate Abitrexate
pemetrexed Alimta
pralatrexate Folotyn
raltitrexed Tomudex
Purine analogues cladribine Leustatin
clofarabine Clolar
fludarabine Fludara
mercaptopurine Purinethol
nelarabine Arranon
pentostatin Nipent
thioguanine Tabloid
Pyrimidine analogues capecitabine Xeloda
cytarabine Cytosar-U
floxuridine FUDR
fluorouracil Adrucil
gemcitabine Gemzar
Other hydroxyurea Droxia, Hydrea
Antimicrotubule Agents Epothilones ixabepilone Ixempra
Halichondrin B analogue eribulin mesylate Halaven
Taxanes paclitaxel Taxol
albumin-bound paclitaxel, nab-paclitaxel Abraxane
docetaxel Taxotere
cabazitaxel Jevtana
Vinca alkaloids vinblastine Velban, Velsar
vincristine Vincasar PFS
liposomal vincristine Marqibo
vinorelbine Navelbine
Protein synthesis inhibitors Cephalotaxine omacetaxine mepesuccinate Synribo
Topoisomerase I inhibitors Camptothecin derivatives etirinotecan pegol

irinotecan Camptosar
topotecan Hycamptin
Quinoline alkaloids camptothecin

Topoisomerase II inhibitors Anthracenedione mitoxantrone Novantrone
Anthracyclines daunorubicin Cerubidine
liposomal daunorubicin DaunoXome
doxorubicin Adriamycin PFS
liposomal doxorubicin Doxil
epirubicin Ellence
idarubicin Idamycin
valrubicin Valstar
Epipodophyllotoxins etoposide/etoposide phosphate Toposar, Etopophos
teniposide Vumon
Other amonafide

Other Antitumor antibiotic bleomycin Blenoxane
dactinomycin Cosmegen
mitomycin Mutamycin
Aspariginase derivatives e. coli derived asparaginase Elspar
erwinia derived asparaginase Erwinaze
pegaspargase Oncaspar
Hypomethylating Agents azacitidine Vidaza
decitabine Dacogen
Retinoic acid derivatives alitretinoin Panretin
bexarotene Targretin
isotretinoin Accutane
tretinoin ATRA
Telomerase template antagonist imetelstat

Other arsenic trioxide Trisenox

mitotane Lysodren
trabectedin Yondelis
denileukin diftitox Ontak
octreotide Sandostatin, Sandostatin LAR
dexamethasone/prednisone Decadron

Hormonal Agents
Type of Agent Development Name Generic Name(s) Trade
Name(s)
Notes
Selective androgen receptor modulator (SARM) GTX-024 enobosarm Osterine
Androgen receptor antagonist
nilutamide Nilandron, Anandron

bicalutamide Casodex

flutamide Eulexin, Apimid
MDV3100 enzalutamide Xtandi
Aromatase inhibitor CGS 20267 letrozole Femara
FCE-24304 exemestane Aromasin

anastrozole Arimidex
Estrogen receptor antagonist
fulvestrant Faslodex
Selective estrogen receptor modulator (SERM)
tamoxifen Nolvadex, Soltamox
LY-139481 raloxifene Evista, Keoxifene

toremifene Fareston
Selective estrogen receptor degrader (SERD) ARN-810


LH-RH analogues and antagonists
degarelix Firmagon

leuprolide Lupron

triptorelin Trelstar

goserelin Zoladex
Other
abiraterone Zytiga

megestrol acetate Megace

estramustine Emcyt, Estracyt

ketoconazole


Other
Target Development Name(s) Generic Name(s) Trade
Name(s)
Notes
ADORA3 (A3AR) CF102


ANGPT1/2 (ANG1/2) AMG 386 trebananib

Arginine ADI-PEG 20 pegargiminase

Bcl-2 ABT-263, ABT-737 navitoclax

AT101


GDC-0199, ABT-0199, ABT-199, RG7601 venetoclax

GX15-070 obatoclax

G3139 oblimerson Genasense
BRD2/3/4 OTX015


CPAA NEO-102, NPC-IC ensituximab

CXCR4 BMS-936564, MDX-1338 ulocuplumab

LY2510924


DOT1L EPZ-5676


EZH2 EPZ-6438, E7438


Farnesyl protein transferase (FTase) IND 58359 tipifarnib Zarnestra
FGFR1 HGS1036, FP-1039, GSK3052230


Folate receptor EC145 vintafolide
folate-vinca alkaloid conjugate
EC1456

Small molecule-drug conjugate
Gamma-secretase MK0752


HDAC 4SC-201 resminostat
CRA-024781, PCI-24781 abexinostat
FK228 romidepsin Istodax
LBH589 panobinostat Faridak
MK-0683 vorinostat Zolinza
MS-275, SNDX-275 entinostat

PXD101 belinostat Beleodaq
HDM2/P53 SAR405838, MI-773


HSP27 OGX-427 apatorsen

HSP90 17-AAG, KOS-953 tanespimycin

AT13387


AUY922 luminespib

Debio 0932


IPI-504 retaspimycin

SNX-5422


STA-9090 ganetespib

XL888


IDH1 AG-120


IDO 1-methyl-d-tryptophan indoximod

KDM1A (LSD1) GSK2879552

KIF11 (KSP/EG5) ARRY-520 filanesib

4SC-205


MDM2 RG7388, RO5503781


Mesothelin MORAB-009 amatuximab

Microtubule BAL101553


Notch Pathway MK0752


PF-03084014


REGN421


RO4929097, R4733


PARP ABT-888 veliparib

AG-014699, PF-01367338 rucaparib

AZD2281 olaparib

BMN 673 talazoparib

BSI-201 iniparib

MK4827 niraparib

Phosphotidylserine
bavituximab

PMSA BIND-014



PORCN LGK974


PP2A LB-100


PPAR-γ CS 7017, RS5444


Proteasome LDP 341, MLN341, PS-341 bortezomib Velcade
PR-171 carfilzomib Kyprolis
PTCH GDC-0449 vismodegib Erivedge
Smoothened GDC-0449 vismodegib Erivedge
LDE225 erismodegib

LY2940680 taladegib

STAT3 OPB-31121


TLR8 VTX-2337, VTX-378 motolimod

XPO1 (CRM1) KPT-330 selinexor

Other BBI503


BBI608


CC-4047 pomalidomide Pomalyst thalidomide derivative
CC-5013 lenalidomide Revlimid thalidomide analog

thalidomide Thalomid
NHS-IL12



​​​​​​​​​​​​​​​​​​

NOTE: To suggest additions or changes, please contact us here.​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

Contributors: Jonathan L. Aston, Pharm.D., Christine M. Lovly, M.D., Ph.D.

Suggested Citation: Aston, J.L., C. Lovly. 2014. Anticancer Agents. My Cancer Genome http://www.mycancergenome.org/content/other/molecular-medicine/anticancer-agents/ (Updated December 18).

Last Updated: December 18, 2014

Disclaimer: The information presented at MyCancerGenome.org is compiled from sources believed to be reliable. Extensive efforts have been made to make this information as accurate and as up-to-date as possible. However, the accuracy and completeness of this information cannot be guaranteed. Despite our best efforts, this information may contain typographical errors and omissions. The contents are to be used only as a guide, and health care providers should employ sound clinical judgment in interpreting this information for individual patient care.